Search Results - "SCHREIBER, Karin"
-
1
Structure-guided engineering of the affinity and specificity of CARs against Tn-glycopeptides
Published in Proceedings of the National Academy of Sciences - PNAS (30-06-2020)“…The potency of adoptive T cell therapies targeting the cell surface antigen CD19 has been demonstrated in hematopoietic cancers. It has been difficult to…”
Get full text
Journal Article -
2
IL-15 in tumor microenvironment causes rejection of large established tumors by T cells in a noncognate T cell receptor-dependent manner
Published in Proceedings of the National Academy of Sciences - PNAS (14-05-2013)“…A major challenge of cancer immunotherapy is the persistence and outgrowth of subpopulations that lose expression of the target antigen. IL-15 is a potent…”
Get full text
Journal Article -
3
Cooperation of genes in HPV16 E6/E7-dependent cervicovaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogens
Published in Carcinogenesis (New York) (13-11-2020)“…Abstract Human papillomavirus (HPV) infection is necessary but insufficient for progression of epithelial cells from dysplasia to carcinoma-in situ (CIS) to…”
Get full text
Journal Article -
4
Impact of TCR Diversity on the Development of Transplanted or Chemically Induced Tumors
Published in Cancer immunology research (01-02-2020)“…Burnet postulated that the diversity of T-cell receptors (TCR) allows T cells to protect against the development of cancers that display antigens with a…”
Get more information
Journal Article -
5
Densely Granulated Murine NK Cells Eradicate Large Solid Tumors
Published in Cancer research (Chicago, Ill.) (15-04-2012)“…Natural killer (NK) cells inhibit early stages of tumor formation, recurrence, and metastasis. Here, we show that NK cells can also eradicate large solid…”
Get full text
Journal Article -
6
Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse model
Published in Journal for immunotherapy of cancer (01-05-2023)“…BackgroundTreatment of some blood cancers with T cells that express a chimeric antigen receptor (CAR) against CD19 have shown remarkable results. In contrast,…”
Get full text
Journal Article -
7
Multiple cancer-specific antigens are targeted by a chimeric antibody receptor on a single cancer cell
Published in JCI insight (01-11-2019)Get full text
Journal Article -
8
Assessment of coronary flow reserve: comparison between contrast-enhanced magnetic resonance imaging and positron emission tomography
Published in Journal of the American College of Cardiology (06-03-2002)“…The study compared flow reserve indices by magnetic resonance imaging (MRI) with quantitative measures of coronary angiography and positron emission tomography…”
Get full text
Journal Article -
9
Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma
Published in Immunity (Cambridge, Mass.) (21-06-2016)“…Genetically modified T cells expressing chimeric antigen receptors (CARs) demonstrate robust responses against lineage restricted, non-essential targets in…”
Get full text
Journal Article -
10
Bystander killing of cancer requires the cooperation of CD4(+) and CD8(+) T cells during the effector phase
Published in The Journal of experimental medicine (25-10-2010)“…Cancers frequently evade cytotoxic T lymphocyte-mediated destruction through loss or down-regulation of tumor antigens and antigen-presenting major…”
Get full text
Journal Article -
11
One CD4+TCR and One CD8+TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication
Published in Clinical cancer research (15-04-2024)“…To achieve eradication of solid tumors, we examined how many neoantigens need to be targeted with how many T-cell receptors (TCR) by which type of T cells…”
Get full text
Journal Article -
12
Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation
Published in Clinical cancer research (01-06-2016)“…Cancers usually contain multiple unique tumor-specific antigens produced by single amino acid substitutions (AAS) and encoded by somatic nonsynonymous single…”
Get full text
Journal Article -
13
Tracking the Common Ancestry of Antigenically Distinct Cancer Variants
Published in Clinical cancer research (01-03-2001)“…In the months and years after first diagnosis, cancers often show an increase in their malignancy such as faster growth, resistance to chemo- and/or hormonal…”
Get full text
Journal Article Conference Proceeding -
14
E-102 Destruction of the tumor microenvironment by neoantigen-specific T cells prevents relapse of therapy-resistant cancer variants
Published in Journal of acquired immune deficiency syndromes (1999) (01-04-2019)“…Microorganisms frequently escape host defenses by generating heritable variants. Cancer cells replicate more slowly than most microorganisms, but variants…”
Get full text
Journal Article -
15
Abstract 3238: Engineering chimeric antigen receptors for adoptive T cell therapy of cancers that express the Tn antigen
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Chimeric antigen receptors (CARs) have shown remarkable promise in treating hematological malignancies, especially those expressing CD19 antigen. On the other…”
Get full text
Journal Article -
16
Abstract 3587: TCR-transduced T cells targeting a truncal mutation caused by a nsSNV destroy large solid tumors despite intratumoral genetic heterogeneity
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Most if not all cancers have individually specific, so-called unique antigens that we discovered in 1995 to be caused by somatic tumor-specific, non-synonymous…”
Get full text
Journal Article -
17
Spleen Cells from Young Donors Eradicate Large Tumors–Response
Published in Clinical cancer research (01-11-2012)Get full text
Journal Article -
18
CD4 + T cells with convergent TCR recombination reprogram stroma and halt tumor progression in adoptive therapy
Published in Science immunology (13-09-2024)“…Cancers eventually kill hosts even when infiltrated by cancer-specific T cells. We examined whether cancer-specific T cell receptors of CD4 T cells (CD4TCRs)…”
Get more information
Journal Article -
19
Abstract LB073: Adoptive transfer of one CD4TCR and one CD8TCR targeting autochthonous neoantigens are essential and sufficient for eradication of naturally heterogeneous solid tumors
Published in Cancer research (Chicago, Ill.) (05-04-2024)“…Despite advances in checkpoint blockade therapy or adoptive transfer of tumor-infiltrating lymphocytes (TILs), achieving cure remains challenging, but success…”
Get full text
Journal Article -
20
Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1-Resistant Tumors Leading to Tumor Eradication
Published in Cancer immunology research (01-02-2017)“…Adoptively transferred CD8 T cells can stabilize the size of solid tumors over long periods of time by exclusively recognizing antigen cross-presented on tumor…”
Get more information
Journal Article